LSE:AZN (AstraZeneca Plc)

About AZN

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

AstraZeneca Plc (LSE: AZN) Latest News

Investing Articles

One super dividend stock I’d buy along with AstraZeneca plc

This firm’s impressive finances make it a serious potential pairing in my portfolio with AstraZeneca plc (LON: AZN).

Read more »

Investing Articles

Why this dividend growth stock could be a better buy than AstraZeneca plc

Roland Head explains why he's not buying AstraZeneca plc (LON:AZN) today.

Read more »

Investing Articles

Why I’m not buying FTSE 100 giants AstraZeneca plc and Barclays plc for their dividends

Edward Sheldon looks at drugs giant AstraZeneca plc (LON: AZN) and banking behemoth Barclays plc (LON: BARC) and explains why…

Read more »

Investing Articles

Top stocks for August

We asked our analysts to share their top stock picks for the coming month.

Read more »

Investing Articles

AstraZeneca plc’s shock plunge is a buying opportunity for the brave

This could be the moment to buy AstraZeneca plc (LON: AZN) that you have been waiting for, says Harvey Jones.

Read more »

Investing Articles

Is AstraZeneca plc a falling knife to catch after dropping 15% today?

AstraZeneca plc (LON: AZN) could be one of best bargains of the FTSE 100 (INDEXFTSE: UKX) right now.

Read more »

Investing Articles

Why I’m considering FTSE 100 income and growth champion AstraZeneca plc

AstraZeneca plc (LSE: AZN) looks attractive to me today.

Read more »

Investing Articles

2 FTSE 100 stocks for retirement income AND growth

These two FTSE 100 (INDEXFTSE:UKX) stocks could deliver above-average income and strong capital growth.

Read more »

Investing Articles

2 FTSE 100 dividend stocks I’d buy in May

Roland Head highlights two stocks with the potential for long-term income growth.

Read more »

Investing Articles

Does cancer breakthrough make this stock a better buy than AstraZenenca plc?

Should investors ditch AstraZeneca plc (LON:AZN) in favour of this promising AIM-listed biotech firm?

Read more »

Investing Articles

2 ‘evergreen’ Neil Woodford picks I’d buy now

These two stalwarts could power your portfolio for years to come.

Read more »

Investing Articles

2 FTSE 100 growth giants that could fund your retirement

These two rising FTSE 100 (INDEXFTSE:UKX) stocks could help you to a comfortable old age.

Read more »